I read for a degree in Natural Sciences at Cambridge University where I was subsequently awarded a Ph.D. for studies in synthetic organic chemistry in the group of Professor Steven V. Ley FRS. I then spent 2 years as a post-doctoral research associate in the group of Professor Barry Trost at Stanford University, working on transition metal catalysed processes and their application in the synthesis of bioactive natural products. I spent 6.5 years in the Chemical Development group at GSK in Stevenage, developing synthetic routes and supporting regulatory files for exploratory APIs for a range of diseases in various clinical phases of development. Since 2012, I have worked in the Quality group at the European Medicines Agency, coordinating the review of applications for new and generic medicines, and supporting the Quality Working Party in the development of new guidelines. I am the EMA Topic Lead for starting materials.